Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/341905
COMPARTIR / EXPORTAR:
SHARE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Rationale for combined therapies in severe-to-critical COVID-19 patients |
Autor: | Gonzaga, Aitor CSIC; Andreu, Etelvina; Hernández-Blasco, Luis M.; Meseguer, Rut; Al-Akioui-Sanz, Karima; Soria-Juan, Bárbara; Sanjuan-Gimenez, Jose Carlos; Ferreras, Cristina; Tejedor, Juan Ramón CSIC ORCID ; López-Lluch, Guillermo CSIC ORCID CVN ; Goterris, Rosa; Maciá, Loreto; Sempere-Ortells, Jose M.; Hmadcha, Abdelkrim CSIC ORCID; Borobia, Alberto; Vicario, Jose L.; Bonora, Ana; Aguilar-Gallardo, Cristobal; Poveda, Jose L.; Arbona, Cristina; Alenda, Cristina; Tarín, Fabian; Marco, Francisco M.; Merino, Esperanza; Jaime, Francisco; Ferreres, José; Figueira, Juan Carlos; Cañada-Illana, Carlos; Querol, Sergio; Guerreiro, Manuel; Eguizabal, Cristina; Martín-Quirós, Alejandro; Robles-Marhuenda, Ángel; Pérez-Martínez, Antonio; Solano, Carlos; Soria, Bernat | Palabras clave: | COVID-19 Cytokine storm Immunomodulation Mesenchymal stromal cells SARS-CoV-2 Advanced therapies |
Fecha de publicación: | 2023 | Editor: | Frontiers Media | Citación: | Frontiers in Immunology 14: 1232472 (2023) | Resumen: | An unprecedented global social and economic impact as well as a significant number of fatalities have been brought on by the coronavirus disease 2019 (COVID-19), produced by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Acute SARS-CoV-2 infection can, in certain situations, cause immunological abnormalities, leading to an anomalous innate and adaptive immune response. While most patients only experience mild symptoms and recover without the need for mechanical ventilation, a substantial percentage of those who are affected develop severe respiratory illness, which can be fatal. The absence of effective therapies when disease progresses to a very severe condition coupled with the incomplete understanding of COVID-19’s pathogenesis triggers the need to develop innovative therapeutic approaches for patients at high risk of mortality. As a result, we investigate the potential contribution of promising combinatorial cell therapy to prevent death in critical patients. | Versión del editor: | http://dx.doi.org/10.3389/fimmu.2023.1232472 | URI: | http://hdl.handle.net/10261/341905 | DOI: | 10.3389/fimmu.2023.1232472 | Identificadores: | e-issn: 1664-3224 |
Aparece en las colecciones: | (CABD) Artículos (PTI Salud Global) Colección Especial COVID-19 |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Rationale for combined_Gonzaga_PV_Art2023.pdf | 2,19 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
Page view(s)
13
checked on 05-may-2024
Download(s)
9
checked on 05-may-2024
Google ScholarTM
Check
Altmetric
Altmetric
Este item está licenciado bajo una Licencia Creative Commons